Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $20.0000 (5.82%) ($18.6000 - $20.6000) on Wed. Jan. 31, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.85% (three month average) | RSI | 65 | Latest Price | $20.0000(5.82%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 4.4% a day on average for past five trading days. | Weekly Trend | CAPR advances 6.8% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) EWG(8%) EWI(8%) PEJ(8%) SKYY(8%) TBT(8%) | Factors Impacting CAPR price | CAPR will decline at least -2.925% in a week (0% probabilities). GLD(-9%) TLT(-8%) GDX(-8%) SLV(-7%) SIL(-6%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.925% (StdDev 5.85%) | Hourly BBV | 0 () | Intraday Trend | 4.7% | | | |
|
5 Day Moving Average | $19.2(4.17%) | 10 Day Moving Average | $17.82(12.23%) | 20 Day Moving Average | $17.27(15.81%) | To recent high | -27.3% | To recent low | 37% | Market Cap | $394m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |